Evidence map›Paper›PMID 39369248›Full record

ArticleActa neuropathologica communications2024

Non-supratentorial YAP1- fused ependymomas: report of two cases.

Leiming Wang, Lei Cheng, Yongjuan Fu, Hua Dong, Yanlei Xiong, Dehong Lu, Yueshan Piao, Lianghong Teng

Abstract readCase ReportsLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. ZFTA::YAP1-rearranged ependymoma: is still ZFTA or already YAP?Acta neuropathologica communications · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Leiming Wang *Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. wangleiming0918@163.com.
Lei ChengDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Yongjuan FuDepartment of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Hua DongZhejiang Key Laboratory of Digital Technology in Medical Diagnostics, Hangzhou, Zhejiang Province, 310013, China.
Yanlei XiongDepartment of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Dehong LuDepartment of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Yueshan Piao *Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
Lianghong Teng *Department of Pathology, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.

Funding

Beijing Hospitals Authority Clinical Medicine Development of Special Funding ZYLX202113Beijing Nova Program Z201100006820149
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adaptor Proteins, Signal TransducingEpendymomaTranscription FactorsYAP-Signaling ProteinsAdultBrain NeoplasmsFemaleHumansMalePhosphoproteinsAdaptor Proteins, Signal TransducingPhosphoproteinsTranscription FactorsYAP1 protein, humanYAP-Signaling ProteinsEpendymomaInfratentorial ependymomaMethylationNGSYAP1

Identifiers

PMID39369248
PMCPMC11452944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.